Craig R. Shadle - Concepedia

Author

Craig R. Shadle

United States Military Academy

Also Known As

C R Shadle, C Shadle, C.R. Shadle, Craig R. Shadle, Craig Shadle

Publications

350

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Buffalo BioLabs Orlando Clinical Research Center

About

Craig R. Shadle is an author at United States Military Academy specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	179
2	Natural Sciences	1	1	127
3	Biochemistry	1	1	127
4	Chemical Biology	1	1	127
5	Clinical Nutrition	1	1	10

Craig R. Shadle

Publications

318

Citations

H-Index

Page 1

	Year	Citations
Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity Craig R. Shadle, Yih Lee, Anup Majumdar, The Journal of Clinical Pharmacology Healthy SubjectsImmunologyReceptor AntagonistPharmacotherapyPotential Inductive Effects	2004	127
Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging Koen Van Laere, Jan de Hoon, Guy Bormans, Clinical Pharmacology & Therapeutics	2012	43
Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects Thomas Marbury, Phung L. Ngo, Craig R. Shadle, The Journal of Clinical Pharmacology	2011	33
Lack of Pharmacokinetic and Pharmacodynamic Interaction between Rizatriptan and Paroxetine Michael R. Goldberg, Richard C. Lowry, Donald G. Musson, The Journal of Clinical Pharmacology	1999	30
Rizatriptan, a Novel 5-HT<SUB>1D/1B</SUB> Agonist for Migraine: Single- and Multiple-Dose Tolerability and Pharmacokinetics in Healthy Subjects Timothy Olah, Michael R. Goldberg, Y. Lee, The Journal of Clinical Pharmacology Cluster HeadacheHealthy SubjectsPharmacological StudyPsychotropic MedicationMigraine Headache	2000	29
Lack of Effect of Aprepitant or Its Prodrug Fosaprepitant on QTc Intervals in Healthy Subjects Thomas Marbury, Bo Jin, Deborah Panebianco, Anesthesia & Analgesia	2009	18
A Double‐Blind, Placebo‐Controlled Evaluation of the Effect of Oral Doses of Rizatriptan 10 mg on Oral Contraceptive Pharmacokinetics in Healthy Female Volunteers Craig R. Shadle, G. Frank Liu, Michael R. Goldberg The Journal of Clinical Pharmacology	2000	15
Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone Wen Lin, Hwa-ping Feng, Craig R. Shadle, European Journal of Clinical Pharmacology Oral ContraceptiveViral HepatitisPharmacologyAntiviral TherapyHepatitis	2014	13
A Single‐Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects Craig R. Shadle, M. Gail Murphy, Yang Liu, Clinical Pharmacology in Drug Development NutritionDietary ExposureReceptor AntagonistPharmacotherapySingle‐dose Bioequivalence	2012	10

Page 1